Seattle, Washington--(Newsfile Corp. - January 6, 2022) - Pervasip Corp. (OTC Pink: PVSP) ("Pervasip" and the "Company") a developer of companies and technologies in high value emerging markets, and its subsidiaries, Artizen Corporation ("Artizen") and Zen Asset Management LLC ("ZAM"), a diversified asset management company that was founded to acquire, develop, and support companies and technologies in the cannabis industry, today announced the appointment of George Jordan as Chief Financial and Chief Operating Officer of Pervasip and its subsidiaries.
George has spent the past 10 years deeply involved in the operation of various cannabis cultivation and distribution operations, managing all aspects of growing and processing cannabis, financing and accounting and raising upwards of $15 million dollars.
German Burtscher, Pervasip's President & CEO, said, "I am extremely excited by the appointment of George as our new CFO & COO. George has a proven track record of performance in business management, finance and the cannabis industry. As a cofounder of Artizen Cannabis Company and ZAM he has led various operational and financial aspects in the development of several cultivation facilities. He has also spearheaded the restructuring we just completed at ZAM and is recognized by all of our staff as a consummate leader with the patience and discipline to help us achieve our goals. I am excited to have George on my side as we aggressively pursue our growth strategies and improve financial health and equity value for our shareholders."
ZAM provides services to several customers in Washington State, including four licensed cultivation facilities and one licensed processing facility, under a series of consulting, leasing, intellectual property licensing and other long-term agreements. ZAM also owns the IP to one of the most successful cannabis brands, ArtizenTM. As one of Washington's original cannabis brands, ArtizenTM - branded products are the all-time fourth best-selling in Washington across all product categories, and the all-time third in flower. The commitment to quality and consistency behind Artizen™ has built a substantial following, fueling more than $69 million in wholesale sales to a distribution network with more than 200 retailers, corresponding to more than $200 million in retail value since inception in 2015. ZAM is looking to expand its service into Oregon and California through similar long-term arrangements with cannabis licensees operating in these states.
"I'm personally thrilled to accept this appointment," added George Jordan, the Company's new CFO & COO. "We have an incredible team, a newly streamlined organization which will allow us to take advantage of not only our leading brand, but also of all of our various assets to grow sales and earnings with organic market development and acquisitions. I am looking forward to executing that plan, continuing to build a strong financial foundation and building shareholder value."
Biography
Prior to joining Pervasip, George Jordan was a co-founder of Artizen Cannabis Company, a licensed cannabis company in Washington state and ZAM, a diversified asset management company that was founded to acquire, develop, and support companies and technologies in the cannabis industry. Mr. Jordan brings more than 15 years of experience in business management, finance, and business development largely in government agencies, hospitality, and legal sectors. A licensed attorney in Washington state since 2012, Jordan brings an accomplished background in start-up management, operations, and overall business acumen. He received his Master of Business Administration degree from Alaska Pacific University (Anchorage, AK), an L.L.M. in taxation from the University of Washington School of Law (Seattle, WA), and has a history of progressive management roles in administrative and consulting services.
Pervasip Corporation
Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM's existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com.
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as may, would, could, will, likely, except, anticipate, believe, intend, plan, forecast, project, estimate, outlook, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company's business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company's ability to secure financing on reasonable terms. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company's periodic disclosure statements. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all of such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
For further information, please contact:
T: 855-464-2535, Extension 1
E: info@pervasip.net
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109263
